Abselion contributes to BioTechniques interview on innovation to adoption

13 April 2026

BioTechniques recently featured an interview with Dale Gordon, who recently joined Abselion as Chair of the Board, exploring what it takes for life science technologies to move from innovation into practical, real-world use.

Drawing on leadership experience across life science tools, bioprocessing and advanced technologies, Dale discusses the factors that shape successful adoption in laboratory and production environments. The interview covers practical considerations including usability, workflow integration, robustness, consistency and long-term value.

The discussion also looks at the role of measurement and data in supporting informed decision-making, and why successful technologies must align not only with scientific need, but also with the realities of day-to-day use.

Read the full interview in BioTechniques: here.